Coulibaly D - Search Results

1

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.

Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Kone AK, Guindo AB, Traore K, Sissoko M, Diallo DA, Diarra I, Kouriba B, Daou M, Dolo A, Baby M, Sissoko MS, Sagara I, Niangaly A, Traore I, Olotu A, Godeaux O, Leach A, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, Takala SL, Lyke KE, House B, Lanar DE, Dutta S, Heppner DG, Plowe CV. Thera MA, et al. Among authors: coulibaly d. PLoS One. 2010 Feb 4;5(2):e9041. doi: 10.1371/journal.pone.0009041. PLoS One. 2010. PMID: 20140214 Free PMC article. Clinical Trial.

2

Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S.

Agarwal A, Guindo A, Cissoko Y, Taylor JG, Coulibaly D, Koné A, Kayentao K, Djimde A, Plowe CV, Doumbo O, Wellems TE, Diallo D. Agarwal A, et al. Among authors: coulibaly d. Blood. 2000 Oct 1;96(7):2358-63. Blood. 2000. PMID: 11001883 Free article.

3

A molecular marker for chloroquine-resistant falciparum malaria.

Djimdé A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourté Y, Coulibaly D, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV. Djimdé A, et al. Among authors: coulibaly d. N Engl J Med. 2001 Jan 25;344(4):257-63. doi: 10.1056/NEJM200101253440403. N Engl J Med. 2001. PMID: 11172152 Free article.

4

Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: parasitologic resistance versus therapeutic efficacy.

Plowe CV, Doumbo OK, Djimde A, Kayentao K, Diourte Y, Doumbo SN, Coulibaly D, Thera M, Wellems TE, Diallo DA. Plowe CV, et al. Among authors: coulibaly d. Am J Trop Med Hyg. 2001 May-Jun;64(5-6):242-6. doi: 10.4269/ajtmh.2001.64.242. Am J Trop Med Hyg. 2001. PMID: 11463110 Clinical Trial.

5

Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility.

Rowe JA, Raza A, Diallo DA, Baby M, Poudiougo B, Coulibaly D, Cockburn IA, Middleton J, Lyke KE, Plowe CV, Doumbo OK, Moulds JM. Rowe JA, et al. Among authors: coulibaly d. Genes Immun. 2002 Dec;3(8):497-500. doi: 10.1038/sj.gene.6363899. Genes Immun. 2002. PMID: 12486610

6

Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali.

Coulibaly D, Diallo DA, Thera MA, Dicko A, Guindo AB, Koné AK, Cissoko Y, Coulibaly S, Djimdé A, Lyke K, Doumbo OK, Plowe CV. Coulibaly D, et al. Among authors: coulibaly s. Am J Trop Med Hyg. 2002 Dec;67(6):604-10. doi: 10.4269/ajtmh.2002.67.604. Am J Trop Med Hyg. 2002. PMID: 12518850 Clinical Trial.

7

Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria.

Lyke KE, Diallo DA, Dicko A, Kone A, Coulibaly D, Guindo A, Cissoko Y, Sangare L, Coulibaly S, Dakouo B, Taylor TE, Doumbo OK, Plowe CV. Lyke KE, et al. Among authors: coulibaly s, coulibaly d. Am J Trop Med Hyg. 2003 Sep;69(3):253-9. Am J Trop Med Hyg. 2003. PMID: 14628940

8

Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria.

Djimdé AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV. Djimdé AA, et al. Among authors: coulibaly d. Am J Trop Med Hyg. 2003 Nov;69(5):558-63. Am J Trop Med Hyg. 2003. PMID: 14695097

9

A comparison of anemia in hemoglobin C and normal hemoglobin A children with Plasmodium falciparum malaria.

Diallo DA, Doumbo OK, Dicko A, Guindo A, Coulibaly D, Kayentao K, Djimdé AA, Théra MA, Fairhurst RM, Plowe CV, Wellems TE. Diallo DA, et al. Among authors: coulibaly d. Acta Trop. 2004 May;90(3):295-9. doi: 10.1016/j.actatropica.2004.02.005. Acta Trop. 2004. PMID: 15099817

10

Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali.

Lyke KE, Dicko A, Kone A, Coulibaly D, Guindo A, Cissoko Y, Traoré K, Plowe CV, Doumbo OK. Lyke KE, et al. Among authors: coulibaly d. Vaccine. 2004 Aug 13;22(23-24):3169-74. doi: 10.1016/j.vaccine.2004.01.054. Vaccine. 2004. PMID: 15297070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters